| Image-guided Minimally Invasive Robotic Surgery Using Preoperative CT Scan for Gastric Cancer Patients (NCT01338948) | Yonsei University | 2009-08-01 |
| Xeloda Plus Paclitaxel in Gastric Cancer With Liver Metastasis (NCT01167049) | Peking University Cancer Hospital & Institute | 2009-08-01 |
| The Maintenance Treatment of UFT in Advanced Gastric Cancer (NCT02903498) | Fudan University | 2009-08-01 |
| Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma (NCT00917384) | Eli Lilly and Company | 2009-08-01 |
| Attenuated SOX as First-line Treatment in Elderly Patients With Relapsed or Metastatic Gastric Cancer (NCT00961077) | Soonchunhyang University Hospital | 2009-08-01 |
| Study of Cediranib Plus Cisplatin Plus Capecitabine/S-1 in Japanese Gastric Cancer Patients (NCT00960349) | AstraZeneca | 2009-08-01 |
| Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial (NCT00941655) | National Cancer Institute (NCI) | 2009-07-22 |
| The Functional and Clinicopathological Roles and Therapeutic Implication of Connective Tissue Growth Factor in Peritoneal Metastasis of Gastric Cancer (NCT01627119) | National Taiwan University Hospital | 2009-07-01 |
| Palliative Radiotherapy for Symptomatic Locally Advanced Gastric Cancer: A Phase II Trial (NCT01341756) | National University Hospital, Singapore | 2009-07-01 |
| Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer (NCT00911820) | Dana-Farber Cancer Institute | 2009-07-01 |
| Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients (NCT00952003) | Arbeitsgemeinschaft medikamentoese Tumortherapie | 2009-07-01 |
| The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding (NCT02150447) | National Cancer Center, Korea | 2009-06-01 |
| Acceptability of Less Harmful Alternatives to Cigarettes (NCT00957424) | Roswell Park Cancer Institute | 2009-06-01 |
| A Study of Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric Cancer (NCT00952497) | ACT Biotech, Inc | 2009-06-01 |
| Postoperative Chemoradiotherapy With S-1 in Gastric Cancer (NCT01824004) | Chonnam National University Hospital | 2009-04-01 |
| A Study of Bevacizumab (Avastin) Versus Placebo in Combination With Capecitabine (Xeloda) and Cisplatin as First-Line Therapy for Advanced Gastric Cancer (NCT00887822) | Hoffmann-La Roche | 2009-03-01 |
| The Natural History of Solid Organ Cancer Stem Cells (SOCSC) (NCT00923052) | National Cancer Institute (NCI) | 2009-02-09 |
| AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer (NCT00719550) | Amgen | 2009-02-01 |
| Sorafenib. ICORG 06-41, V4 (NCT01158287) | Cancer Trials Ireland | 2009-02-01 |
| Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction (NCT00849615) | Krankenhaus Nordwest | 2009-02-01 |
| Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin (NCT00831571) | Dana-Farber Cancer Institute | 2009-02-01 |
| Trial of XP (Capecitabine/CDDP) Simvastatin in Advanced Gastric Cancer Patients (NCT01099085) | Samsung Medical Center | 2009-02-01 |
| Quality of Life After Oesophageal or Gastric Cancer Surgery (NCT01657175) | Region Skane | 2009-01-01 |
| A Trial of Reconstruction After Distal Gastrectomy for Gastric Cancer (NCT01065688) | Wakayama Medical University | 2009-01-01 |
| The Effect of Neoadjuvant Chemotherapy on Locally Advanced Gastric Cancer (NCT01444755) | Haydarpasa Numune Training and Research Hospital | 2009-01-01 |
| Nutrition and Lifestyle Study Cohort of Gastric Cancer in China (NCT02216955) | State Key Laboratory of Cancer Biology | 2009-01-01 |
| Enterotomy Closure and Minimally Invasive Gastrectomy (NCT04901585) | Federico II University | 2009-01-01 |
| Oxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric Cancer (NCT00985556) | Yonsei University | 2009-01-01 |
| Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients (NCT01271582) | Asan Medical Center | 2009-01-01 |
| Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer (NCT00836992) | Mayo Clinic | 2009-01-01 |
| Docetaxel + Oxaliplatin + S-1 in Potentially Operable Gastric or Gastroesophageal Adenocarcinoma (NCT00816543) | Sanofi | 2008-12-01 |
| Efficacy and Safety Study of Combination Therapy With Docetaxel-oxaliplatin-capecitabine in Patients With Advanced Gastric Adenocarcinoma and Intermediate General Status (NCT00733616) | Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) | 2008-11-01 |
| Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric Cancer (NCT00980603) | National Cancer Center, Korea | 2008-11-01 |
| A Study Comparing Billroth II With Roux-en-Y Reconstruction for Gastric Cancer (NCT01257711) | National Healthcare Group, Singapore | 2008-10-09 |
| Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking (NCT00790569) | Butler Hospital | 2008-09-01 |
| Development and Validation of Perceived Fatigue Meaning Scale on Walking Program (NCT01178775) | National Taiwan University Hospital | 2008-09-01 |
| Human Leukocyte Antigen (HLA) - A*2402 Restricted Peptide Vaccine Therapy in Patients With Advanced Gastric Cancer (NCT00845611) | Kinki University | 2008-09-01 |
| Trial of S-1 Plus Cisplatin in Gastric Cancer (NCT01198392) | Sun Yat-sen University | 2008-09-01 |
| Gastrectomy Plus Prophylactic Cholecystectomy in Gastric Cancer Surgery (NCT00757640) | Italian Research Group for Gastric Cancer | 2008-09-01 |
| Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal Cancer (NCT00865982) | Charite University, Berlin, Germany | 2008-09-01 |
| A Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine Tumors (NCT00745381) | Memorial Sloan Kettering Cancer Center | 2008-08-01 |
| Non-Interventional Study of Xeloda (Capecitabine) in Patients With Gastric Cancer (NCT02274376) | Hoffmann-La Roche | 2008-08-01 |
| Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma (NCT00737438) | Memorial Sloan Kettering Cancer Center | 2008-08-01 |
| Pharmacogenomic Study (Adjuvant Chemotherapy) (NCT01470404) | Samsung Medical Center | 2008-07-10 |
| Effects of Early Oral Feeding After Resection of Gastric Cancer (NCT00606619) | The Catholic University of Korea | 2008-07-01 |
| Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors (NCT00722228) | Hadassah Medical Organization | 2008-07-01 |
| Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) vs Standard CT (NCT00718354) | Thrombosis Research Institute | 2008-07-01 |
| Response Rate and Side Effects of Preoperative Chemotherapy (TOX Regimen) in Patients With Locally Advanced Operable Gastric Adenocarcinoma (NCT01672333) | Milad Hospital | 2008-06-01 |
| Study of TS-1 or TS-1 + PSK for Gastric Cancer Patients (NCT00687843) | Tokyo Metropolitan Oncology Group | 2008-06-01 |
| Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer (NCT00654160) | Mayo Clinic | 2008-06-01 |
| Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric Cancer (NCT00678535) | Merck KGaA, Darmstadt, Germany | 2008-06-01 |
| A Multicenter Phase II Study of Neoadjuvant Docetaxel, Cisplatin and Capecitabine and Protocolized Surgery in Resectable Gastric Cancer (NCT01517009) | Jeroen Bosch Ziekenhuis | 2008-06-01 |
| Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers (NCT00848783) | NYU Langone Health | 2008-05-01 |
| FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer (NCT00673673) | Yale University | 2008-05-01 |
| Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer (NCT00681252) | Tokyo University | 2008-05-01 |
| Study of Cetuximab to Treat Gastric Cancer (NCT00699881) | Fudan University | 2008-05-01 |
| Docetaxel With or Without Vandetanib in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer (NCT00683787) | Roswell Park Cancer Institute | 2008-05-01 |
| Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer (NCT00681577) | Tokyo University | 2008-05-01 |
| Sorafenib Gastric Cancer Asian Phase I Study (NCT00663741) | Bayer | 2008-05-01 |
| Phase II Study of ABI-007 for Gastric Cancer (NCT00661167) | Taiho Pharmaceutical Co., Ltd. | 2008-04-01 |
| Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer (NCT00978549) | Cambridge University Hospitals NHS Foundation Trust | 2008-04-01 |
| Postoperative Chemotherapy and Chemo-radiotherapy for Resected Gastric Cancer (NCT00718913) | Hellenic Oncology Research Group | 2008-04-01 |
| Proteiomic Fingerprints of Gastric Juice (NCT00834236) | Kaohsiung Veterans General Hospital. | 2008-03-01 |
| Gastric Cancer Screening Quality Improvement System Establishment (NCT02457624) | Seoul National University Hospital | 2008-03-01 |
| Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer (NCT00639327) | Japan Clinical Cancer Research Organization | 2008-03-01 |
| Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer (NCT00660205) | University of Aarhus | 2008-02-01 |
| Gastric Cancer RAD001 Study (NCT01514110) | Chinese University of Hong Kong | 2008-01-23 |
| Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach (NCT00601705) | Case Comprehensive Cancer Center | 2008-01-05 |
| Interobserver Agreement of Endoscopic Ultrasonography and Endoscopic Sonoelastography in the Evaluation of Lymph Nodes (NCT01033695) | Odense University Hospital | 2008-01-01 |
| Study of Oxaliplatin, Calcium Folinate, and 5-Fluorouracil as Neoadjuvant Chemotherapy for Resectable Advanced Gastric Cancer (NCT00591045) | Peking University | 2008-01-01 |
| Evaluation of Four Reconstructions After Total Gastrectomy (NCT00677456) | Tang-Du Hospital | 2008-01-01 |
| Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking (NCT00666978) | Lisa Sanderson Cox, PhD | 2007-12-01 |
| Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer (NCT00595972) | Fudan University | 2007-11-01 |
| Imatinib, Capecitabine, and Cisplatin in Treating Patients With Unresectable or Metastatic Stomach Cancer (NCT00601510) | Technical University of Munich | 2007-11-01 |
| Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer (NCT00568529) | Fudan University | 2007-10-01 |
| Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer (NCT00553683) | Rutgers, The State University of New Jersey | 2007-10-01 |
| The Preventive Effect of Helicobacter Pylori Eradication on the Development of Gastric Cancer (NCT00596401) | Showa Inan General Hospital | 2007-09-01 |
| Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy (NCT00896467) | Centre Oscar Lambret | 2007-09-01 |
| Oxaliplatin and 5-Fluorouracil With or Without Docetaxel in Elderly Patients (>65 y) With Stomach and Esophagus Cancer (NCT00737373) | Krankenhaus Nordwest | 2007-08-01 |
| Adjuvant Treatment of Gastric Cancer With Chemotherapy and Chemoradiotherapy (TRACE) (NCT00512304) | University Hospital, Rouen | 2007-08-01 |
| Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors (NCT00511576) | Mirati Therapeutics Inc. | 2007-08-01 |
| Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer (NCT01212887) | Cancer Research UK | 2007-08-01 |
| Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer (NCT00514020) | Vanderbilt-Ingram Cancer Center | 2007-08-01 |
| Sorafenib as a Second Line Treatment in Patients With Advanced or Metastatic Gastric Cancer (NCT00595985) | Fudan University | 2007-07-01 |
| Familial Colorectal Cancer Registry in Hispanics (NCT00927680) | University of Puerto Rico | 2007-07-01 |
| Trial of 2nd Generation Anti-CEA Designer T Cells in Gastric Cancer (NCT00429078) | Roger Williams Medical Center | 2007-07-01 |
| A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED) (NCT00539968) | Merck Sharp & Dohme LLC | 2007-06-01 |
| A Randomized Study Comparing Autofluorescence Imaging(AFI) Followed by Narrow Band Imaging(NBI) With Videoendoscopy for the Detection of High Risk Lesions of Stomach (NCT01132534) | National University Hospital, Singapore | 2007-06-01 |
| Sunitinib, Irinotecan, Fluorouracil, and Leucovorin In Treating Patients With Advanced Stomach Cancer or Gastroesophageal Cancer (NCT00524186) | Roswell Park Cancer Institute | 2007-05-01 |
| The Effect of Preoperative Docetaxel, Cisplatin and Capecitabine on Serum RUNX3 Hypermethylation Status in Patients With Gastric and Lower Oesophagus Adenocarcinoma (NCT00674167) | National University Hospital, Singapore | 2007-05-01 |
| Continuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGC (NCT00767377) | Fudan University | 2007-05-01 |
| Laparoscopic Ultrasound Guided Tissue Sampling in Patients With Cancer of the Upper Gastrointestinal Tract (NCT00511264) | Odense University Hospital | 2007-05-01 |
| Study of Weekly DCF to Treat Advanced Gastric Cancer (NCT00568971) | Fudan University | 2007-04-01 |
| Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection (NCT00464893) | Neovii Biotech | 2007-04-01 |
| A Study of Xeloda (Capecitabine) in Combination With Chemotherapy in Patients With Advanced and/or Metastatic Gastric Cancer. (NCT00454636) | Hoffmann-La Roche | 2007-03-01 |
| A Study of Xeloda (Capecitabine) as First-Line Chemotherapy in Patients With Advanced or Metastatic Gastric Cancer. (NCT00436241) | Hoffmann-La Roche | 2007-03-01 |
| A Comparison Between D1 and D2 Lymphadenectomy in Gastric Cancer : A Prospective Randomized Controlled Trial (NCT00447746) | Tata Memorial Hospital | 2007-03-01 |
| Perioperative Immunonutrition, Phagocytic and Bactericidal Activity of Blood Platelets in Gastric Cancer Patients (NCT01704664) | Medical University of Bialystok | 2007-03-01 |
| A Study of Cetuximab(Erbitux) With Cisplatin and Capecitabine(Xeloda)as 1st Line Treatment in the Advanced Gastric Cancer (NCT00477711) | Peking University | 2007-03-01 |
| Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. (NCT00423254) | Mannkind Corporation | 2007-02-01 |